Hover a dot or row, or tab through the dots · bars scaled to the largest round ($137M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-370879
First filed2020-07-14
Latest2020-07-14
Sought$137M
Sold$137M
Investors38
Exemptions506(b)
021-323159
First filed2018-10-10
Latest2020-05-11
Sought$59.3M
Sold$59.3M
Investors38
Exemptions506(b)
021-318040
First filed2018-07-30
Latest2018-07-30
Sought$6.5M
Sold$6.5M
Investors2
Exemptions506(b)
021-306354
First filed2018-02-26
Latest2018-02-26
Sought$7.7M
Sold$7.7M
Investors12
Exemptions506(b)
Who backs VelosBio Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2020-07-14
Related persons
Name
Relationship
David Johnson
RelationshipExecutive Officer, Director
Alan Colowick
RelationshipDirector
Min Cui
RelationshipDirector
Cam Gallagher
RelationshipDirector
Jayson Punwani
RelationshipDirector
Karan Takhar
RelationshipDirector
Jonathan Tobin
RelationshipDirector
Clayton Knox
RelationshipExecutive Officer
Langdon Miller
RelationshipExecutive Officer
Scott Karchmer
RelationshipExecutive Officer
Facts
As its latest Form D states them
Industry
Biotechnology
State
California (CA)
Exemptions
Rule 506(b)
First filed
2018-02-26
Latest filing
2020-07-14
Who backs VelosBio Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)